Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Masafumi, Masuda"'
Autor:
Noriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Hyogo Naoi, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Mikio Toyoshima, Masato Kono, Shiro Imokawa, Masato Fujii, Taisuke Akamatsu, Naoki Koshimizu, Koshi Yokomura, Hiroyuki Matsuda, Yusuke Kaida, Yutaro Nakamura, Masahiro Shirai, Kazutaka Mori, Masafumi Masuda, Tomoyuki Fujisawa, Naoki Inui, Hiroaki Sugiura, Hiromitsu Sumikawa, Masashi Kitani, Kazuhiro Tabata, Noriyoshi Ogawa, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial pneumonia (IIP). Howev
Externí odkaz:
https://doaj.org/article/d38798487a204e818e149454dbc5d89e
Autor:
Hideki Yasui, Naoki Inui, Tomoyuki Fujisawa, Masato Karayama, Noriyuki Enomoto, Yutaro Nakamura, Shigeki Kuroishi, Hisano Ohba, Koshi Yokomura, Jun Sato, Masaki Sato, Naoki Koshimizu, Mikio Toyoshima, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Takafumi Suda
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 12 (2018)
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who
Externí odkaz:
https://doaj.org/article/42f07d03af3244768cadc4ec89999e5f
Autor:
Kazuko Ikegaya, Junichi Tokuhama, Seiji Harada, Masafumi Masuda, Atsuko Saito, Kana Fushimi, Ken Tsuchiya, Hiroki Ashizawa, Kazuma Saratani
Publikováno v:
Japanese Journal of Infection Prevention and Control. 36:149-156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af8bbbd5fb3f0ba29aea95d9050e89ad
https://doi.org/10.4058/jsei.36.149
https://doi.org/10.4058/jsei.36.149
Autor:
Taisuke Akamatsu, Toshihiro Shirai, Masato Kato, Dai Hashimoto, Hideki Yasui, Naoki Inui, Takafumi Suda, Koshi Yokomura, Hiroshi Hayakawa, Kyotaro Ide, Mikio Toyoshima, Shigeki Kuroishi, Kazumasa Yasuda, Hideki Suganuma, Takashi Yamada, Masafumi Masuda, Kingo Chida
Publikováno v:
Allergology International, Vol 61, Iss 2, Pp 323-329 (2012)
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) in a single inhaler is the mainstay of asthma management and salmeterol/fluticasone combination (SFC) and fixed-dose formoterol/budesonide combi
Externí odkaz:
https://doaj.org/article/f41d6434bdca4ba6b63dd064c80b71d4
Autor:
Noriyuki Enomoto, Mikio Toyoshima, Naoki Koshimizu, Hiroyuki Matsuda, Takafumi Suda, Shiro Imokawa, Kazuhiro Asada, Tomoyuki Fujisawa, Yusuke Kaida, Yuzo Suzuki, Naoki Inui, Masafumi Masuda, Kazuki Furuhashi, Koushi Yokomura, Hiroshi Hayakawa, Hironao Hozumi, Takashi Yamada, Yutaro Nakamura, Hideki Kusagaya, Masato Karayama
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:1867-1877
Background Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor, has been shown to improve survival in non-small cell lung cancer (NSCLC). The possible involvement of PD-1 axis in the pathogenesis of inflammatory lung disease, such as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece68f795a490c02a12759c7253800a2
https://doi.org/10.2147/copd.s214610
https://doi.org/10.2147/copd.s214610
Autor:
Kouji Takamori, Junichi Tokuhama, Hiroshi Shibata, Seiji Harada, Atsuko Saito, Kazuma Saratani, Ken Tsuchiya, Yuri Kasezawa, Masafumi Masuda, Kazuko Ikegaya, Kana Fushimi
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:136-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ec1f67c6ece8c5dc3d61a8a3de789ea
https://doi.org/10.4058/jsei.33.136
https://doi.org/10.4058/jsei.33.136
Autor:
Kouji Takamori, Masafumi Masuda, Junichi Tokuhama, Kazuko Ikegaya, Hiroshi Shibata, Ken Tsuchiya, Kazuma Saratani, Kana Fushimi, Seiji Harada, Yuri Kasezawa, Atsuko Saito
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:56-61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc6ed1922e99444100219596f34d088
https://doi.org/10.4058/jsei.33.56
https://doi.org/10.4058/jsei.33.56
Autor:
Yoshio Taguchi, M. Toyoshima, Hiroshi Ishii, Sakae Homma, Hiroki Takahashi, T. Suda, T. Akamatsu, S. Akagawa, H. Matsuda, Y. Yamano, Hiroshi Mukae, S. Imokawa, K. Yokomura, Yoshinori Tanino, Hajime Takizawa, Y. Inoue, Shigeo Muro, Y. Kaida, N. Koshimizu, H. Uruga, M. Kanai, Noriyuki Enomoto, Naohiko Inase, T. Sano, Motoyasu Kato, Masafumi Masuda, Yasuhiko Nishioka, S. Izumi, Naoki Hamada
Publikováno v:
B46. IDIOPATHIC INTERSTITIAL PNEUMONIA: NATURAL HISTORY.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91ca88276bab99883ba4f9e6fb8b08f9
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3390
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3390
Autor:
Shiro Imokawa, Yutaro Nakamura, Masato Karayama, Masaki Sato, Naoki Koshimizu, Noriyuki Enomoto, Koshi Yokomura, Masafumi Masuda, Takafumi Suda, Tomoyuki Fujisawa, Naoki Inui, Takashi Yamada, Mikio Toyoshima, Shigeki Kuroishi, Toshihiro Shirai
Publikováno v:
European Journal of Cancer. 58:30-37
Objectives Single agent maintenance therapy is widely accepted for advanced non-squamous non small cell lung cancer (NSCLC). However, there is no consensus on the initial and maintenance phase regimens, and the clinical benefit of adding bevacizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84dcd47e86a85d89f40d7bd0b8b1634c
https://doi.org/10.1016/j.ejca.2016.01.013
https://doi.org/10.1016/j.ejca.2016.01.013
Autor:
Shigeki Kuroishi, Takashi Yamada, Naoki Inui, Naoki Koshimizu, Masaki Sato, Hisano Ohba, Yutaro Nakamura, Jun Sato, Masafumi Masuda, Takafumi Suda, Tomoyuki Fujisawa, Masato Karayama, Hideki Yasui, Koshi Yokomura, Noriyuki Enomoto, Toshihiro Shirai, Mikio Toyoshima
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 12 (2018)
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb55e44a157e7ecba11d3c121d7dc81a
https://doaj.org/article/42f07d03af3244768cadc4ec89999e5f
https://doaj.org/article/42f07d03af3244768cadc4ec89999e5f